Humanised recombinant antibodies for human cancer therapy
Humanisation of rodent mAbs by CDR-grafting is now a standard procedure for reducing immunogenicity and recruiting human effector functions with ten humanised mAbs approved for use and many more in development. This project aimed to develop two anti-cancer therapeutics aimed at exploiting two tumour...
Main Author: | Davidson, Lisa |
---|---|
Published: |
University of Strathclyde
2009
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501643 |
Similar Items
-
Production and study of polysialylated antibodies for improved cancer therapy
by: Constantinou, Antony
Published: (2006) -
Cancer therapy : origin and application
by: Roberts, Fiona L.
Published: (2012) -
Design and cancer-targeting potential of antibody-based molecules directed against carcinoembryonic antigen
by: Huhalov, Alexandra
Published: (2004) -
Efficient trial design for new cancer therapies
by: Hall, Peter Stephen
Published: (2012) -
Signalling pathways in angiogenesis as targets for cancer therapy
by: Brader, Sharon Lesley
Published: (2005)